Optomed has established an international scientific advisory board. The board consists of globally recognized and scientifically merited medical doctors specializing in ophthalmology and neuro-ophthalmology, with advanced experience on artificial intelligence applied to detection of ophthalmic conditions.
The scientific advisory board consists of the following members:
Robert Chang, MD, Associate Professor of Ophthalmology, Stanford University Medical Center, USA
Nina Hautala, MD, PhD, Professor of Ophthalmology, Oulu University Hospital, Finland
Dan Milea, MD, PhD, Professor of Ophthalmology, Head, Visual Neuroscience Group, Singapore Eye Research Institute, Singapore National Eye Centre and Duke-NUS Medical School, Singapore
Tunde Peto, MD, PhD, Professor of Clinical Ophthalmology, Queen’s University Belfast, UK
Daniel Ting, MD, PhD, Associate Professor of Ophthalmology, Head, AI and Digital Innovation, Singapore Eye Research Institute, Singapore National Eye Centre and Duke-NUS Medical School, Singapore
The main goal of the advisory board is to guide and assist Optomed with research on retinal imaging, focusing on the use of handheld fundus cameras and artificial intelligence in eye disease screening. Other goals of the advisory board cooperation include supporting Optomed’s product development, education of company’s stakeholders and raising awareness on handheld cameras and artificial intelligence solutions. This cooperation supports Optomed’s strategy to take eye screenings to primary care, closer to the customer, to improve the accessibility of care.
Clinical Director, Optomed